A detailed history of Quest Partners LLC transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 7,751 shares of DAWN stock, worth $122,155. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,751
Previous 83 9238.55%
Holding current value
$122,155
Previous $1.14 Million 9338.02%
% of portfolio
0.01%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$12.72 - $16.03 $97,536 - $122,918
7,668 Added 9238.55%
7,751 $108 Million
Q2 2024

Aug 06, 2024

SELL
$12.03 - $17.69 $109,869 - $161,562
-9,133 Reduced 99.1%
83 $1.14 Million
Q1 2024

May 09, 2024

BUY
$13.56 - $17.46 $98,120 - $126,340
7,236 Added 365.45%
9,216 $152 Million
Q4 2023

Feb 09, 2024

BUY
$9.68 - $15.37 $19,166 - $30,432
1,980 New
1,980 $28.9 Million

Others Institutions Holding DAWN

About Day One Biopharmaceuticals, Inc.


  • Ticker DAWN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,461,104
  • Market Cap $1.16B
  • Description
  • Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...
More about DAWN
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.